Picture of VolitionRX logo

VNRX — VolitionRX News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Volition Files Patent For Nu.Q(Tm) Covid-19 Triage Test And Commences Proof Of Concept Studies

April 23 (Reuters) - VolitionRX Ltd  VNRX.A :
    * VOLITION FILES PATENT FOR NU.Q(TM) COVID-19 TRIAGE TEST
AND
COMMENCES PROOF OF CONCEPT STUDIES
    * VOLITIONRX -WORKING WITH COLLABORATORS TO INVESTIGATE IF
EXISTING NU.Q(TM) EPIGENETIC ASSAYS CAN PREDICT WHICH PATIENTS
WITH COVID-19 ARE MOST AT RISK

Source text for Eikon:  ID:nPn6N5ZPZa 
Further company coverage:  VNRX.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on VolitionRX

See all news